Sonoma Pharmaceuticals Crescita futura
Future criteri di controllo 2/6
Sonoma Pharmaceuticals is forecast to grow earnings and revenue by 53.7% and 27.1% per annum respectively while EPS is expected to grow by 81.2% per annum.
Informazioni chiave
53.7%
Tasso di crescita degli utili
81.2%
Tasso di crescita dell'EPS
Pharmaceuticals crescita degli utili | 23.7% |
Tasso di crescita dei ricavi | 27.1% |
Rendimento futuro del capitale proprio | n/a |
Copertura analitica | Low |
Ultimo aggiornamento | 15 Jul 2024 |
Aggiornamenti recenti sulla crescita futura
Recent updates
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Oct 17Market Cool On Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) Revenues Pushing Shares 33% Lower
Aug 27The Market Lifts Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Shares 75% But It Can Do More
Jul 12Investors Aren't Entirely Convinced By Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) Revenues
May 26Sonoma Pharmaceuticals GAAP EPS of -$0.29, revenue of $3.99M
Aug 11Does Sonoma Pharmaceuticals (NASDAQ:SNOA) Have A Healthy Balance Sheet?
Sep 30Sonoma Pharmaceuticals reports FQ2 results
Nov 20Previsioni di crescita degli utili e dei ricavi
Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
---|---|---|---|---|---|
3/31/2026 | 21 | -2 | N/A | 1 | 2 |
3/31/2025 | 16 | -3 | N/A | -2 | 2 |
6/30/2024 | 13 | -5 | -3 | -3 | N/A |
3/31/2024 | 13 | -5 | -2 | -2 | N/A |
12/31/2023 | 12 | -5 | -5 | -5 | N/A |
9/30/2023 | 12 | -6 | -4 | -4 | N/A |
6/30/2023 | 13 | -6 | -5 | -5 | N/A |
3/31/2023 | 13 | -5 | -6 | -6 | N/A |
12/31/2022 | 13 | -7 | -5 | -5 | N/A |
9/30/2022 | 13 | -6 | -5 | -5 | N/A |
6/30/2022 | 13 | -5 | -5 | -5 | N/A |
3/31/2022 | 13 | -5 | -4 | -4 | N/A |
12/31/2021 | 12 | -6 | -4 | -4 | N/A |
9/30/2021 | 15 | -5 | -3 | -3 | N/A |
6/30/2021 | 17 | -5 | -2 | -2 | N/A |
3/31/2021 | 19 | -5 | -4 | -3 | N/A |
12/31/2020 | 21 | -3 | -6 | -5 | N/A |
9/30/2020 | 20 | -4 | -7 | -7 | N/A |
6/30/2020 | 19 | -5 | -8 | -8 | N/A |
3/31/2020 | 18 | -4 | -5 | -5 | N/A |
12/31/2019 | 18 | -5 | -4 | -4 | N/A |
9/30/2019 | 19 | -6 | -5 | -5 | N/A |
6/30/2019 | 19 | -8 | -8 | -8 | N/A |
3/31/2019 | 19 | -12 | -12 | -12 | N/A |
12/31/2018 | 18 | -13 | -12 | -12 | N/A |
9/30/2018 | 18 | -14 | -12 | -12 | N/A |
6/30/2018 | 17 | -14 | -11 | -11 | N/A |
3/31/2018 | 17 | -14 | N/A | -12 | N/A |
12/31/2017 | 17 | -12 | N/A | -12 | N/A |
9/30/2017 | 16 | -9 | N/A | -11 | N/A |
6/30/2017 | 14 | -9 | N/A | -10 | N/A |
3/31/2017 | 13 | -9 | N/A | -8 | N/A |
12/31/2016 | 11 | -9 | N/A | -7 | N/A |
9/30/2016 | 10 | -14 | N/A | -8 | N/A |
6/30/2016 | 8 | -16 | N/A | -9 | N/A |
3/31/2016 | 9 | -15 | N/A | -9 | N/A |
12/31/2015 | 11 | -13 | N/A | -10 | N/A |
9/30/2015 | 12 | -14 | N/A | -8 | N/A |
6/30/2015 | 14 | -10 | N/A | -8 | N/A |
3/31/2015 | 14 | -8 | N/A | -7 | N/A |
12/31/2014 | 13 | 1 | N/A | -6 | N/A |
9/30/2014 | 13 | 6 | N/A | -5 | N/A |
6/30/2014 | 14 | 5 | N/A | -5 | N/A |
3/31/2014 | 14 | 4 | N/A | -5 | N/A |
12/31/2013 | 14 | -6 | N/A | -4 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: SNOA is forecast to remain unprofitable over the next 3 years.
Guadagni vs Mercato: SNOA is forecast to remain unprofitable over the next 3 years.
Guadagni ad alta crescita: SNOA is forecast to remain unprofitable over the next 3 years.
Ricavi vs Mercato: SNOA's revenue (27.1% per year) is forecast to grow faster than the US market (8.9% per year).
Ricavi ad alta crescita: SNOA's revenue (27.1% per year) is forecast to grow faster than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Insufficient data to determine if SNOA's Return on Equity is forecast to be high in 3 years time